Taiwan, Celgene To Expand Cooperation On Cancer-Drug Development
This article was originally published in PharmAsia News
Executive Summary
U.S.-based Celgene said it plans to increase its collaboration with Taiwan's government and its institutions in developing new treatments for lung and liver cancers.